In the latest episode of Let’s Talk Rare, Owen Bryant & Georgie Rack delve into the world of drug development in rare diseases.
They are joined by the brilliant Rob Freishtat, president of Uncommon Cures. Rob brings unique insights on who the key stakeholder are in developing drugs and the many ways that we can bring them together in order to improve and enhance the delivery of much-needed therapies.
